Background. Both chronic kidney disease (CKD) and post-angiographic acute kidney injury (AKI) are regarded as risks factors for long-term mortality after coronary angiography. On the other hand, acute haemodynamic disturbances requiring haemodynamic support have a strong impact on both the incidence of AKI and on prognosis after coronary angiography. The aim of this study was to determine the impact of CKD and AKI on long-term prognosis after coronary angiography among hospital survivors and to determine relationships with haemodynamic variables. Methods. We studied 2439 patients who underwent coronary angiography or percutaneous coronary intervention. Relationships between both CKD and AKI and mortality or cardiovascular diseases were measured using unadjusted and adjusted Cox models for case-mix and laboratory variables. Results. Multivariable Cox regression analysis identified CKD as an independent predictor of long-term mortality [adjusted hazard ratio (AHR) 1.51; 95% confidence interval (95% CI) 1.07-2.13] and composite end points (AHR 1.72; 95% CI 1.40-2.11). Lower estimated glomerular filtration ratio levels below 50 mL/min/1.73 m 2 were significantly associated with mortality after adjustments. A similar association was found even in haemodynamically stable patients. AKI was also a predictor of long-term composite end points (AHR 1.64; 95% CI 1.09-2.46); however, its impact was attenuated in haemodynamically stable patients. Conclusions. Among hospital survivors, CKD is an independent predictor for both long-term mortality and composite end points, regardless of haemodynamic conditions. AKI is also a predictor of long-term prognosis; however, its impact may be attenuated in haemodynamically stable hospital survivors.
Introduction
Patients with chronic kidney disease (CKD) are at increased risk for death and cardiovascular events [1, 2] . In addition to this, growing numbers of CKD patients are expected to undergo coronary angiography and percutaneous coronary intervention [3, 4] , and CKD is regarded as an independent predictor of long-term mortality after percutaneous coronary intervention [5] [6] [7] [8] . Post-angiographic acute kidney injury (AKI) is a post-angiographic complication that increases risk for both in-hospital and long-term mortality [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . However, previous studies examining AKI included haemodynamically unstable patients. Importantly, acute haemodynamic disturbances that require intra-aortic balloon pump or catecholamine haemodynamic support exert a strong impact on both the incidence of AKI and on prognosis after coronary angiography [26] [27] [28] [29] . In previous studies, haemodynamic parameters were examined as possible risk factors for both AKI and prognosis [11] [12] [13] . This indicates that AKI from haemodynamic causes has been included in post-angiographic AKI and that prognostic impact of post-angiographic AKI may have been affected by haemodynamic factors [11] [12] [13] 26] . However, additional observational studies are needed to separately describe the effects of contrast procedures and haemodynamic factors on outcomes in order to clarify intervention targets in future randomized controlled trials.
The aim of our study was to determine the impact of both CKD and AKI on long-term mortality in patients undergoing coronary angiography. We also performed a subgroup analysis among haemodynamically stable patients.
Materials and methods

Patients
This retrospective study examined a historical cohort of 2439 consecutive patients who gave signed informed consent and who were admitted to Rinku General Medical Center from the middle of 2000 until the end of 2004 to undergo coronary angiography and/or percutaneous coronary intervention. This facility is a central hospital in the southern portion of Osaka prefecture. There was no other central hospital in this region, and regional partnerships with primary care physicians have been well established. Patients who died during the hospital stay (n = 60) were excluded. Other exclusion criteria included end-stage kidney disease undergoing dialysis therapy (n = 57), malignancy (n = 4) and insufficient data {un-available hospital documents (n = 64) and incomplete data [baseline missing (n = 8), follow-up missing (n = 15), missing creatinine and haemoglobin (n = 8) and dosage of radio-contrast missing (n = 30)]}. The final analysis included 2193 patients. In some cases, an intra-aortic balloon pump or percutaneous cardiopulmonary support was used when the cardiac or pulmonary status of the patient was failing. The intra-aortic balloon pump improves diastolic coronary and systemic blood flow and reduces afterload and myocardial work [30] . This system is used for myocardial infarction with cardiogenic shock and for high-risk patients before primary percutaneous coronary angioplasty. The percutaneous cardiopulmonary support system consists of a centrifugal pump with its control system, membrane oxygenator, measurement devices for blood flow and pressure and a heating system for temperature conditioning of blood [31] . We regarded 105 patients as haemodynamically unstable who presented with shock (defined as systolic blood pressure below 80 mm Hg), who used the intra-aortic balloon pump or percutaneous cardiopulmonary support, who were intubated into the trachea due to pulmonary congestion or who used catecholamine within 12 h of the procedure. The remaining 2088 patients were regarded as haemodynamically stable. We also performed a subgroup analysis among haemodynamically stable patients. A number of patients underwent more than one procedure during the observation period. In such cases, only the first procedure was included. Non-ionic low osmolar contrast agents [iomeprol (Iomeron Ⓡ 350; Eisai, Tokyo, Japan) or iopromide (Proscope Ⓡ 370; Tanabe Seiyaku, Osaka, Japan)] were used for all patients. Patients usually received intravenous hydration before the procedures, mostly with normal saline solution. Neither N-acetylcysteine nor bicarbonate prophylaxis was used before the procedure. This study was approved by the ethics committee of Rinku General Medical Centre. Values are described as mean ± SD or %. CKD, chronic kidney disease; AKI, acute kidney injury; eGFR, estimated glomerular filtration ratio; PCI, percutaneous coronary artery intervention; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker. Values are described as rate per 1000 patient-years (number of events). CKD, chronic kidney disease; AKI, acute kidney injury.
Definitions
The baseline level of kidney function was defined from serum creatinine values that were collected most proximate to the time of angiography and within a few days before the prophylaxis with intravenous fluid. All serum creatinine values within 2 days after angiography were also collected. Serum creatinine was measured by enzymatic methods in the same laboratory. AKI was defined as an absolute serum creatinine increase of at least 0.3 mg/dL or a 50% increase from baseline within 48 h, as proposed by the Acute Kidney Injury Network. Several studies have demonstrated that this degree of change has an impact on outcomes [14, 17, 19, 20] . AKI was classified into three stages, 1, 2 and 3, based on increases in serum creatinine of 1.5-to 2-fold, >2-to 3-fold and >3-fold from baseline, respectively [32] . We also used an alternate AKI definition (an absolute serum creatinine increase of at least 0.5 mg/dL or 25% increase within 48 h [13, 32] ) and performed similar analyses. We selected 48 h as part of the AKI definition for several reasons. First, AKI studies are commonly assessed within 48 h [11, 13, 33] . Second, serum creatinine is not routinely measured at 3 days after angiography in all patients in daily clinical settings. In our cohort, patients with 3 days of creatinine measurements may have had more severe underlying comorbidities. Thus, excluding patients without 3 days of creatinine measurements may raise a strong bias. Finally, the Acute Kidney Injury Network selected the period of 48 h for diagnosis based on evidence that adverse outcomes during small changes in creatinine were observed when creatinine elevations occurred within a 24 to 48-h time frame. This ensured that the process was acute in a clinically relevant time period [32] . The estimated glomerular filtration ratio (eGFR) was calculated using a formula adapted for the Japanese population [34] . CKD was defined as eGFR of <60 mL/min/1.73 m stages IV and V were <30 mL/min/1.73 m 2 . Other baseline variables included age, sex, diabetes [The International Classification of Diseases, Tenth Revision (ICD-10) codes E10-E14], hypertension (ICD-10 codes I10-I15), current smoking history and haemoglobin. Cardiovascular disease included sudden death (ICD-10 codes I46.1, I46.9), ischaemic heart disease (ICD-10 codes I20-I25), heart failure (ICD-10 code I50) and stroke (ICD-10 codes I60-I67).
End points
The primary end point in this study was any cause of death, and the secondary end point was a composite of cardiovascular disease and death, analysed as time to the first event. We measured the occurrence of end points after discharge that included death from any cause and cardiovascular diseases (defined as above) requiring re-hospitalization. We began the observations after discharge from the indexed hospital stay because of two primary considerations. First, it was difficult to determine the cause of death in those who died from AKI or from all other events (the main cause for admission to the hospital). Second, in-hospital deaths occurred within a short and early period. Because the number of deaths was not small, we feared that the Cox proportionality assumption would be violated if they were included in the model.
Data collection
Data were collected by means of source documentation at the end of 2007. The baseline and follow-up data were collected from hospital medical records and discharge abstracts, outpatient visit records, contact from primary care physicians and death certificates. Outcomes were validated by at least two physicians. For patients without end points, the dates of censor were designated as the last day that the patients were confirmed to be alive or event free. The completeness of follow-up was assessed by both the median failure time for censored observations and the Clark-Altman completion score, given as the ratio of the total observed person-time to the potential person-time of follow-up in a study [35] .
Statistical analysis
Results are presented as means ± SD or a percentage of the total. The means of continuous variables were compared using the Student's ttests. Categorical variables were compared using the Fisher's exact test. Cox regression was used to estimate the hazard ratio (HR) of each outcome. The proportional hazards assumption was tested by analysis of Schoenfeld residuals. No violations were observed. Multivariable models were developed by simultaneously taking CKD, AKI and other clinically relevant variables into consideration. Cumulative survival curves were estimated by means of the Kaplan-Meier method and compared by log-rank test. Nonlinear associations for eGFR as a continuous predictor were examined by using restricted splines. P-values <0.05 were considered to indicate statistical significance. Statistical analyses were performed using STATA statistical software version 10 (STATA Corporation, College Station, TX, USA) and R environment for statistical computing, version 2.7.1 [36] .
Results
Characteristics of the cohort
The patient cohort had a mean age of 66.3 ± 11.4 years, and the mean eGFR was 72.1 ± 21.5 mL/1.73 m 2 . The study population had 585 (26.7%) CKD patients with an eGFR below 60 mL/min/1.73 m 2 , while 81 (3.7%) had AKI. Three (3.7%) of the AKI patients showed stage 2 AKI and all others were stage 1. Demographic data are shown in Table 1 . CKD patients were older, more anaemic and more frequently showed a history of diabetes, hypertension and cardiovascular disease than patients without CKD. CKD patients were more likely to develop AKI and to be haemodynamically unstable. AKI patients had lower baseline eGFR, received more contrast and had more haemodynamic instability. The median long-term followup period was 3.8 years (interquartile range, 1.9-5.6 years). The Clark-Altman completion score was 74.1% for death and 75.4% for composite end point. There were a total of 152 deaths, with an overall death rate of 18.1 per 1000 patient-years, while there were a total of 410 composite end points (55.2 per 1000 patient-years). The main cause of death was cardiovascular disease ( Table 2 ). The KaplanMeier estimated risk of death for the entire cohort at 1, 3 and 5 years was 1.7, 4.4 and 7.8%, respectively. eGFR (mL/min/1.73m 2 ) Figure 1A and B) and in the haemodynamically stable group ( Figure 1C and D). Figure 2 shows the multivariable-adjusted estimated logrelative hazard of mortality and composite end points associated with eGFR. This curve indicates a monotonic and significant increase in both events with lower levels of eGFR, and this trend became significant with eGFR below 50 mL/min/1.73 m 2 . The event ratio was relatively stable with higher levels of eGFR. Table 4 shows stratified hazard ratios of mortality and composite end points by CKD groups. As CKD stage advanced, both unadjusted and adjusted hazard ratios significantly increased. Subgroup analyses among stable patients did not alter this trend (Table 4 ). The multivariable-adjusted estimated log-relative hazard of mortality and composite end points associated with eGFR in stable patients showed similar findings to those in the analysis of whole patients (Figure 3 ).
Impact of AKI on long-term end points
Univariate Cox regression analysis showed that AKI was a predictor of both mortality and composite end points [HR (95% CI); 2.61 (1.44-4.71) and 2.59 (1.78-3.78) , respectively, Table 3 ]. The interaction term with AKI and haemodynamic instability was negative (P-values for mortality and composite end points were 0.68 and 0.50, respectively, indicating no interaction). This relationship with composite end points persisted after adjustment for other comorbidities [AHR (95% CI) for mortality and composite end points were 1.53 (0.84-2.91) and 1.64 (1.09-2.46), respectively]. In contrast, multivariable analysis of the haemodynamically stable group showed that AKI was not a predictor of either end point [AHR (95% CI) for mortality and composite end points were 0.97 (0.39-2.45) and 1.32 (0.79-2.23), respectively]. The KaplanMeier curves in the analysis of all patients ( Figure 4A and B) were attenuated in the haemodynamically stable group (Figure 4C and D) .
Results from analyses using the alternate definition of AKI are shown in supplementary Tables 2, 3, 4 and Figure 1 . Although the number of AKI cases increased, AKI was not associated with either end point in haemodynamically stable patients [AHR (95% CI) for mortality and composite end points were 0.91 (0.42-2.00) and 1.27 (0.85-1.90), respectively, supplementary Table 4 ].
Discussion
In a previous study, in-hospital and 1-year mortality rates for a high creatinine cohort (serum creatinine ≥1.8 mg/ dL) were 8.6 and 25.3%, respectively [12] . Other studies that included patients with better kidney function showed 0.7-2.1% for in-hospital or 30-day mortality and~4-5% for 1-year mortality [11, 13, 15] . The fact that our in-hospital mortality was 2.5% indicates that our long-term mortality was similar to or slightly better than those of previous cohorts. Since previous studies began their observation periods from the index hospital stay and included only percutaneous coronary intervention patients, our study population exhibited a somewhat lower mortality rate. Our follow-up ratio was relatively good for a retrospective study, but not perfect. Therefore, it is possible that some events were missed and this may have affected the results. Previous studies have shown that various stages of CKD are independent predictors of long-term mortality after percutaneous coronary intervention [5] [6] [7] [8] 21, 22] . Our study demonstrated that, even after adjustment for AKI, there was a monotonic and significant increase in both mortality and composite end points at eGFR levels below 50 mL/ min/1.73 m 2 . This association also held true for haemodynamically stable patients. These findings suggest that CKD is an independent risk factor that is independent from haemodynamic variables. The Kidney/Dialysis Outcome Quality Initiative guidelines state that all patients with CKD should be considered as belonging to the 'highest risk' group for cardiovascular disease, irrespective of levels of traditional cardiovascular disease risk factors [37] . Our observations are consistent with this guideline and extend the risk of mortality to patients undergoing coronary angiography.
There are several explanations for the poorer outcomes in CKD patients, and one of these may be the severity of the coronary artery disease. A large body of evidence suggests that patients with CKD show a substantial increase in cardiovascular risk that can be explained in part by an increase in traditional risk factors such as hypertension and diabetes, as well as by CKD by itself [1, 2, [38] [39] [40] [41] . Thus, CKD patients are characterized by many risk factors for coronary diseases, and the degree of risk increases with increasing stages of CKD. In fact, it has been reported that heart disease patients with CKD have more severe coronary artery disease [1, 2] and that many CKD patients already have coronary artery diseases at the initiation of dialysis [3, 4] . Another possible explanation for the poorer outcomes is that CKD patients often undergo more complicated treatment courses [42, 43] . Kidney function is one of the important determinants of AKI, and coronary angiography is often avoided in CKD patients because of the risk of AKI. CKD patients who do undergo coronary angiography, regardless of the risk for AKI, may end up with more complicated diseases. These factors are likely to have strong negative impacts on the long-term prognosis for CKD patients after coronary angiography, regardless of their haemodynamic conditions. Some studies have shown that AKI following coronary angiography is associated with long-term mortality [11] [12] [13] [14] . Rihal et al. [11] reported higher mortality rates at 1 and 5 years after the development of AKI (defined as an increase in serum creatinine ≥0.5 mg within 48 h or before dismissal) compared with those who did not develop AKI (12.1 and 44.6% versus 3.7 and 14.5%, respectively). Gruberg et al. [12] showed higher cumulative 1-year mortality rates for those with AKI (defined as an increase in serum creatinine ≥25% within 2 days) in their renal impairment patients (37.7 versus 19.4%), while Dangas et al. [13] showed higher cumulative 1-year mortality rates for those with AKI (defined as an increase in serum creatinine ≥25% and/or ≥0.5 mg/dL at 2 days) in both CKD (22.6 versus 6.9%) and non-CKD (8.0 versus 2.7%) patients. Parikh et al. [14] in a study examining a large acute myocardial infarction cohort with multivariable adjustment showed that AKI (defined as an increase in serum creatinine ≥0.3 mg during the hospitalization) constituted an independent and graded risk for long-term mortality [14] .
Haemodynamic variables, such as hypotension, usage of intra-aortic balloon pumps and congestive heart failure, are some of the strongest predictors of AKI (defined as an increase in serum creatinine ≥25% and/or ≥0.5 mg/dL at 2 days), as reported by Mehran et al. [33] . These variables can cause both AKI and poorer prognosis after coronary intervention. Previous studies did not exclude haemodynamically unstable patients, such that associations between AKI and long-term mortality may have been confounded by haemodynamic instability [26] [27] [28] [29] . In order to evaluate a possible interaction between haemodynamic instability and AKI, we analysed long-term prog- nosis of hospital survivors who were haemodynamically stable. Our results suggested that the impact of AKI on haemodynamically stable patients was attenuated compared with that in our overall patient population. However, the wide confidence intervals associated with these findings made it impossible to determine the exact impact of AKI on the long-term prognosis in our haemodynamically stable patients. This finding is not in conflict with the negative impact of AKI on in-hospital mortality reported in previous studies [11, 12] . In our study, we began observations after discharge from the indexed hospital stay, and our conclusions are valid only for survivors, but not for the entire AKI patient population. Furthermore, we were unable to analyse the impact of CKD and AKI on haemodynamically unstable patients because of the small number of such patients in our study population. The predictive value of CKD and AKI for unstable patients, and AKI for stable patients, thus remains of considerable interest, and findings from carefully conducted prospective observational studies are eagerly anticipated [26] . Our study has several limitations. First, the design of the study (historical cohort) did not allow us to infer causality. Second, the sample size was relatively small. Although the impact of AKI was haemodynamic factor-sensitive, we did not find an interaction, presumably because of the small number of AKI patients. It is possible that an association between AKI and long-term mortality among stable patients could be found in larger cohorts. Third, selection bias may have influenced our results since we tended to reduce the dose of contrast medium and avoided coronary angiography in patients with higher serum creatinine. Fourth, there are many types of AKI definitions, and we could not analyse all of them. Although we used a common and clinically relevant AKI definition which was proposed by the Acute Kidney Injury Network [32] , other definitions have recommended 48 or 72 h after angiography. Our cohort was extracted from daily clinical settings, and not all of the patients stayed in hospital for 48 h. Therefore, it is possible that we may have had more AKI cases if we had observed all the patients at 48 or 72 h. We assume that most of those who were discharged early were haemodynamically stable patients, and AKI cases in stable patients may have been underestimated. Fifth, the definition of haemodynamically unstable is difficult to determine in some cases. Intra-aortic balloon pumps are sometimes used for high-risk patients to prepare for possible deteriorations in haemodynamics. In these cases, we could not accurately determine whether blood pressure was stable because we used this device from whether haemodynamics was stable because disease itself was not severe. Because we regarded patients using this device as haemodynamically unstable, this may have caused a slight underestimation of the haemodynamically stable population. Finally, other causes of AKI were not examined in detail. Although our investigation was conducted with great care, the retrospective nature of this work made it impossible to accurately diagnose cholesterol crystal embolism and acute interstitial nephritis. While cholesterol crystal embolism is relatively rare, it is strongly associated with poor prognosis [44] .
In conclusion, our observational study of hospital survivors after coronary angiography demonstrated that CKD is a strong, independent and graded predictor of long-term mortality and composite end points, regardless of the haemodynamic conditions. AKI is also a predictor of long-term prognosis; however, the impact of AKI on prognosis may be attenuated in haemodynamically stable hospital survivors.
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